companies innovating in obesity treatment glp-1 drugs 2025 Pipeline Update: August - Prime Therapeutics GLP-1 Agonists Weight Loss Drugs

Another condition that may contribute to FGID in FM patients is non-celiac wheat sensitivity (NCWS) [35], a condition in which GI and extraintestinal symptoms are triggered by wheat in the absence of celiac disease (CD) or wheat allergy

Xanthophylls such as lutein and zeaxanthin are integrated into both high-density lipoprotein (HDL) and low-density lipoprotein (LDL) but the carotenes are only present in the LDL fraction [24, 25]

Nigella sativa Its active compound, thymoquinone, exhibits anti-oxidant properties, which could be beneficial in treating psoriasis by addressing the oxidant-anti-oxidant imbalance regularly present in psoriasis

PMID 17070848

Wilson SK and Delk JR 2nd: A new treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis